The occurrence of age-related macular degeneration in the presence of a transferred, confirmed COVID-19

Abstract

BACKGROUND: COVID-19 can affect the eyes and both the anterior and posterior segments of the eye. Retinal complications associated with COVID-19 have been reported.

CLINICAL CASE DESCRIPTION: We present a clinical case of age-related macular degeneration that developed during the acute period of coronavirus infection. A patient with COVID-19 and pneumonia (CT-1) experienced sudden decrease in visual acuity within 1 month. A dark spot appeared in front of the left eye, which did not disappear despite eye movements, and distortion of objects was observed. The disease was manifested acutely. A complete ophthalmological examination revealed a sharp decrease in visual acuity and a positive Amsler test (distortion of lines at a distance of 30 cm). In the field of view, scotomas were noted in the center. Ophthalmoscopy revealed light and dark foci in the central macular zone of the retina. Cptical coherence tomography with an angiographic mode detected severe changes at the level of the neuroepithelium and retinal pigment epithelium with the formation of gray tissue. Aflibercept (approved for use in the Russian Federation, No. LP-003544) was intravitreally prescribed according to the clinical guidelines for treating age-related macular degeneration. After treatment with positive dynamics, visual acuity increased to 1.0, and the thickness of the retina decreased by 102 microns.

CONCLUSION: The key objective in making a correct diagnosis was the use of optical coherence tomography with an angiographic mode. This method allows the visualization of the retinal layers without invasion The angiography mode allows the assessment of the state of the foveolar avascular zone and the density and perfusion of blood vessels, which enable the diagnosis of age-related macular degeneration and choroidal neovascularization. Timely antiangiogenic treatment, that is, a single intraocular injection, completely restored the visual acuity and visual field and normalized the state of the retina according to objective data of optical coherence tomography with angiography mode.

Keywords

COVID-19 / SARS-CoV-2 / age-related macular degeneration / AMD / retina / degeneration / case report

References

[1] Karampelas M, Dalamaga M, Karampela I. Does COVID-19 Involve the Retina? Ophthalmol Ther. 2020;9:693–695. doi: 10.1007/s40123-020-00299-x

[2] Karampelas M., Dalamaga M., Karampela I. Does COVID-19 Involve the Retina? // Ophthalmol Ther. 2020. Vol. 9. P. 693–695. doi: 10.1007/s40123-020-00299-x

[3] Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488–509. doi: 10.4103/ijo.IJO_297_21

[4] Sen M., Honavar S.G., Sharma N., Sachdev M.S. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19 // Indian J Ophthalmol. 2021. Vol. 69, N 3. P. 488–509. doi: 10.4103/ijo.IJO_297_21

[5] Kasymkhanova AT, Kisamedenov NG, Minuarov RE. Changes in the retina and option nerve associated with SARS-CoV-2 (clinical cases). Neurosurgery and Neurology of Kazakhstan. 2022;(3):29–35. doi: 10.53498/24094498_2022_3_29

[6] Касымханова А.Т., Кисамеденов Н.Г., Минуаров Р.Е. Изменения со стороны сетчатки и зрительного нерва — взаимосвязь с SARS-CoV-2 (клинические случаи) // Нейрохирургия и неврология Казахстана. 2022. № 3. С. 29–35. doi: 10.53498/24094498_2022_3_29

[7] Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2021;289(1):116–120. doi: 10.1111/joim.13156

[8] Landecho M.F., Yuste J.R., Gándara E., et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? // J Intern Med. 2021. Vol. 289, N 1. P. 116–120. doi: 10.1111/joim.13156

[9] Gilemzyanova LI, Babushkin AE. Ocular manifestations of SARS-CoV-2. Point of View. East-West. 2022;3:38–44. doi: 10.25276/2410-1257-2022-3-38-44

[10] Гилемзянова Л.И., Бабушкин А.Э. Офтальмологические проявления SARS-CoV-2 // Точка зрения. Восток-Запад. 2022. № 3. С. 38–44. doi: 10.25276/2410-1257-2022-3-38-44

[11] Takhchidi KhP, Takhchidi NKh, Movsesian MKh. COVID-19 in ophthalmic practice. Medicine of Extreme Situations. 2020;(4):53–58. doi: 10.47183/mes.2020.017

[12] Тахчиди Х.П., Тахчиди Н.Х., Мовсесян М.Х. COVID-19 в офтальмологической практике // Медицина экстремальных ситуаций. 2020. № 4. С. 53–58. doi: 10.47183/mes.2020.017

[13] Safronova MA, Stanishevskaya OM, Malinovskaya MA, et al. Central serous chorioretinopathy in patients with coronavirus infection. Modern Problems of Science and Education. 2021;(3):140. doi: 10.17513/spno.30849

[14] Сафронова М.А., Станишевская О.М., Малиновская М.А., и др. Центральная серозная хориоретинопатия у пациентов, перенесших коронавирусную инфекцию // Современные проблемы науки и образования. 2021. № 3. С. 140. doi: 10.17513/spno.30849

[15] David JA, Fivgas GD. Acute macular neuroretinopathy associated with COVID-19 infection. Am J Ophthalmol Case Rep. 2021;24:101232. doi: 10.1016/j.ajoc.2021.101232

[16] David J.A., Fivgas G.D. Acute macular neuroretinopathy associated with COVID-19 infection // Am J Ophthalmol Case Rep. 2021. Vol. 24. P. 101232. doi: 10.1016/j.ajoc.2021.101232

[17] Medvedeva LM. Some aspects of pathogenesis and treatment of age-related macular degeneration. Vitebsk Medical Journal. 2021;20(5):7–14. doi: 10.22263/2312-4156.2021.5.7

[18] Медведева Л.М. Некоторые аспекты патогенеза и лечения возрастной макулярной дегенерации. Вестник Витебского государственного медицинского университета. 2021. Т. 20, № 5. С. 7–14. doi: 10.22263/2312-4156.2021.5.7

[19] Gheorghe A, Mahdi L, Musat O. Age-related macular degeneration. Rom J Ophthalmol. 2015;59(2):74–77.

[20] Gheorghe A., Mahdi L., Musat O. Age-related macular degeneration // Rom J Ophthalmol. 2015. Vol. 59, N 2. P. 74–77.

[21] Norooznezhad AH, Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res. 2021;137:104188. doi: 10.1016/j.mvr.2021.104188

[22] Norooznezhad A.H., Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19) // Microvasc Res. 2021. Vol. 137. P. 104188. doi: 10.1016/j.mvr.2021.104188

[23] Burgos-Blasco B, Güemes-Villahoz N, Santiago JL, et al. Hypercytokinemia in COVID-19: tear cytokine profile in hospitalized COVID-19 patients. Exp Eye Res. 2020;200:108253. doi: 10.1016/j.exer.2020.108253

[24] Burgos-Blasco B., Güemes-Villahoz N., Santiago J.L., et al. Hypercytokinemia in COVID-19: tear cytokine profile in hospitalized COVID-19 patients // Exp Eye Res. 2020. Vol. 200. P. 108253. doi: 10.1016/j.exer.2020.108253

[25] Belyaeva AI, Safronova MA, Stanishevskaya OM, et al. Postcovid ophthalmic manifwstations in the posterior segment of the eye. Modern Problems of Science and Education. 2023;(1):95. doi: 10.17513/spno.32391

[26] Беляева А.И., Сафронова М.А., Станишевская О.М., и др. Постковидные офтальмологические проявления на заднем отрезке глаза // Современные проблемы науки и образования. 2023. № 1. С. 95. doi: 10.17513/spno.32391

RIGHTS & PERMISSIONS

Eco-Vector